Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff...

Published on 10 Feb 2025 on Benzinga · via Yahoo Finance

Pliant Therapeutics, Inc. (NASDAQ:PLRX) stock is trading lower on Monday. On Friday, during...

Read the rest of the article

Start tracking your investments with Statfolio

Pliant Therapeutics, Inc. (PLRX) could be a solid choice for investors given its recent upgrade t...

Zacks · via Yahoo Finance 14 Feb 2025

Pliant Therapeutics, Inc. (NASDAQ:PLRX) stock is trading lower on Monday. On Friday, during...

Benzinga · via Yahoo Finance 10 Feb 2025

On September 24, 2024, Paradigm Biocapital Advisors LP (Trades, Portfolio) marked a significant p...

GuruFocus.com · via Yahoo Finance 1 Oct 2024

The market expects Pliant Therapeutics, Inc. (PLRX) to deliver a year-over-year decline in earnin...

Zacks via Yahoo Finance 7 Mar 2024

Keith Cummings, the CFO of Pliant Therapeutics Inc, sold 9,781 shares of the company on January 1...

GuruFocus.com via Yahoo Finance 22 Jan 2024

Investors are always looking for stocks that are poised to beat at earnings season and Pliant The...

Zacks via Yahoo Finance 10 Nov 2023

Wall Street expects a year-over-year decline in earnings on higher revenues when Pliant Therapeut...

Zacks via Yahoo Finance 7 Nov 2023

Shares of Pliant Therapeutics, Inc. PLRX gained 14.3% on Sep 26 after the company announced that ...

Zacks · via Yahoo Finance 27 Oct 2023

While Pliant Therapeutics, Inc. (NASDAQ:PLRX) shareholders are probably generally happy, the stoc...

Simply Wall St. · via Yahoo Finance 22 Oct 2023

Pliant Therapeutics, Inc. PLRX shares ended the last trading session 14.3% higher at $16.67. The ...

Zacks · via Yahoo Finance 22 Oct 2023